Efficacy and Safety of DAPSone as a Second-line Option in Adult Immune Thrombocytopenia

Clinical trial NCT02627417 · UNKNOWN

Trial details

NCT number: NCT02627417
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Adult Immune Thrombocytopenia (ITP)Dapsone

Start date: 2015-12-01
Primary completion: 2019-05-01
Enrollment: 216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.